In 2018, Orrego et al., investigated the association between the density of CD3+, CD4+, CD8+, CD20+ tumor-infiltrating lymphocytes (TILs), monocytes, CD68+ and CD163+ macrophages with MGMT methylation status in relation to prognosis. The gene discussed is CD163; the disease is neoplasm.